RESUMEN
The aim of this manuscript is to report the case of a 22-year-old adolescent who presented with brownish patches on the skin of her lower legs persistent since the age of eleven years. She was treated by a dermatologist since the age of twelve years with a clinical diagnosis of ochre dermatitis confirmed by a biopsy. The patient was treated for two years without a success and was sent to a vascular surgeon at fourteen years of age. The diagnosis was confirmed, and the venous duplex scan discarded the possibility of a macrocirculation abnormality. The patient was treated with aminaphtone with the normalization of the skin for two years, after which the patches returned and were controlled again with the same medication. As ochre dermatitis may be associated with capillary fragility, the use of aminaphtone is a therapeutic option.
Asunto(s)
Humanos , Femenino , Adolescente , Fragilidad Capilar , Hiperpigmentación , Dermatitis/terapia , Várices , HemosiderinaRESUMEN
BACKGROUND: Among the multiple complex pathophysiological mechanisms underlying Covid-19 pneumonia, immunothrombosis has been shown to play a key role. OBJECTIVE: The aim of the present study was to assess the monthly prevalence of deep venous thrombosis in a university hospital that admitted 5159 patients with Covid-19 in the medical ward and intensive care unit (ICU) and investigate whether there has been an increase in the prevalence of deep vein thrombosis and dead recently. METHOD: A clinical trial was conducted evaluating 5159 patients admitted to the university hospital, Hospital de Base in São Jose do Rio Preto-Brazil, with a positive test for Covid-19, the prevalence of monthly deep venous thrombosis and the increase in thrombotic and events and mortality in March 2020 to April 2021 compared to the previous January and February with March-April of 2021. The evaluated by Fisher's exact test. RESULTS: The prevalence of deep vein thrombosis varied between the months of 0.26% to 7%, with an average of 2.5%. The months of March and April 2021 had a significant increase in venous thrombosis and mortality in relation to the months of January and February 2021. CONCLUSION: The prevalence of deep venous thrombosis was variable during the months evaluated, since the beginning of Covid-19, but there was a significant increase in these last two months.
Asunto(s)
COVID-19 , Trombosis de la Vena , Brasil/epidemiología , Humanos , Prevalencia , Derivación y Consulta , SARS-CoV-2 , Trombosis de la Vena/epidemiologíaRESUMEN
Diarrhea following bariatric surgery may be secondary to multiple causes. The aim of the present study is to report a significant reduction in episodes of diarrhea with the stimulation of the lymphatic system in a patient with post-bariatric diarrhea usingthe Godoy method for the treatment for lymphedema. Case Report: A 40-year-old female patient with obesity was submitted to bariatric surgery, type Gastric bypass (roo-en-wy), 13 years ago. Beginning immediately after surgery, the patient began to have around 12 episodes of diarrhea per day for approximately 11 years. The patient also had lower limb lymphedema and was sent to the Clínica Godoy-Brazil for treatment. The patient underwent the Godoy Method® of intensive treatment for lymphedema. However, the most important finding was the immediate reduction in the number of episodes of diarrhea per day, which went from 12-13 to 2-3 after only one day of treatment. This result regarding diarrhea has been maintained for two years, with the maximum number of seven episodes on some days, which subsequently returned to two to three episodes. The Godoy intensive lymphedema treatment method was effective at reducing the number of episodes of post-bariatric diarrhea, offering a novel treatment option for these patients
Asunto(s)
Humanos , Femenino , Adulto , Diarrea/terapia , Cirugía Bariátrica/efectos adversos , Linfedema/terapia , Sistema LinfáticoRESUMEN
Objective: The aim of the present study was to evaluate epidemiological data of patients seen at a clinic specialized in the treatment of lymphedema. Methods: A retrospective, cross-sectional study was conducted involving data from 150 consecutive patients with lower limb lymphedema in clinical stages II and III treated at the Godoy Clinic in São Jose do Rio Preto. The follow data were collected: sex, age, type of lymphedema (primary or secondary), cause of secondary lymphedema (cancer, trauma, venous disease) and limb dominance. The diagnosis of lymphedema was based on the clinical history and physical examination; in cases of doubt, lymphoscintigraphy of the lower limbs was requested. Descriptive statistics were performed and results were expressed as percentages. Results: Twenty-five (16.66%) of the patients were male and 125 (83.33%) were female. Mean age was 42.52 years (41.8 years among the men and 42.67 years among the women). One hundred nine cases (72.66%) were primary lymphedema and 41 (27.33%) were secondary. Among the secondary cases, 27 (18%) were related to cancer treatment, 10 (6.6%) were linked to trauma and four (2.6%) were cases of phlebolymphedema. Mean age was 51.4 years among the patients with cancer treatment-related lymphedema, 41 years among those with trauma-related lymphedema and 64.25 years among those with phlebolymphedema. The left leg was affected in 61 cases (40.66%), the right leg was affected in 37 cases (24.66%) and lymphedema was bilateral in 52 cases (34.66%). Conclusion: Primary lymphedema was predominant and affected women more than men. Primary lymphedema occurred at an earlier age compared to cancer treatment-related lymphedema and phlebolymphedema. The left leg was affected more often, followed by bilateral lymphedema and, finally, the right leg alone